CHARGEURS SA (CRI.PA) Stock Fundamental Analysis
EPA:CRI - Euronext Paris - Matif - FR0000130692 - Common Stock - Currency: EUR
CRI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 14 industry peers in the Industrial Conglomerates industry. Both the profitability and financial health of CRI have multiple concerns. CRI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CRI has reported negative net income.
CRI had a positive operating cash flow in the past year.
CRI had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CRI reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -0.55%, CRI is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
With a Return On Equity value of -1.81%, CRI is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 3.61%, CRI is doing worse than 64.29% of the companies in the same industry.
CRI had an Average Return On Invested Capital over the past 3 years of 4.83%. This is in line with the industry average of 6.55%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.55% | ||
| ROE | -1.81% | ||
| ROIC | 3.61% |
ROA(3y)1.98%
ROA(5y)2.57%
ROE(3y)6.62%
ROE(5y)8.73%
ROIC(3y)4.83%
ROIC(5y)5.7%
1.3 Margins
CRI's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 4.76%, CRI is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
CRI's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 26.99%, CRI is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
CRI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.76% | ||
| PM (TTM) | N/A | ||
| GM | 26.99% |
OM growth 3Y-18.6%
OM growth 5Y-11.57%
PM growth 3Y-64.16%
PM growth 5Y-45.18%
GM growth 3Y-0.45%
GM growth 5Y-0.47%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRI is destroying value.
Compared to 1 year ago, CRI has about the same amount of shares outstanding.
The number of shares outstanding for CRI has been increased compared to 5 years ago.
Compared to 1 year ago, CRI has a worse debt to assets ratio.
2.2 Solvency
CRI has an Altman-Z score of 1.46. This is a bad value and indicates that CRI is not financially healthy and even has some risk of bankruptcy.
CRI has a Altman-Z score of 1.46. This is in the lower half of the industry: CRI underperforms 71.43% of its industry peers.
The Debt to FCF ratio of CRI is 50.42, which is on the high side as it means it would take CRI, 50.42 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 50.42, CRI is doing worse than 64.29% of the companies in the same industry.
CRI has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
CRI has a Debt to Equity ratio of 1.06. This is in the lower half of the industry: CRI underperforms 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 50.42 | ||
| Altman-Z | 1.46 |
ROIC/WACC0.53
WACC6.79%
2.3 Liquidity
CRI has a Current Ratio of 1.29. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
CRI's Current ratio of 1.29 is on the low side compared to the rest of the industry. CRI is outperformed by 85.71% of its industry peers.
A Quick Ratio of 0.83 indicates that CRI may have some problems paying its short term obligations.
CRI has a worse Quick ratio (0.83) than 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 0.83 |
3. Growth
3.1 Past
The earnings per share for CRI have decreased strongly by -137.41% in the last year.
CRI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -44.13% yearly.
Looking at the last year, CRI shows a decrease in Revenue. The Revenue has decreased by -0.75% in the last year.
Measured over the past years, CRI shows a small growth in Revenue. The Revenue has been growing by 2.64% on average per year.
EPS 1Y (TTM)-137.41%
EPS 3Y-67.43%
EPS 5Y-44.13%
EPS Q2Q%-254.53%
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y-7.38%
Revenue growth 5Y2.64%
Sales Q2Q%8.62%
3.2 Future
The Earnings Per Share is expected to grow by 32.83% on average over the next years. This is a very strong growth
CRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.24% yearly.
EPS Next Y44.78%
EPS Next 2Y88.98%
EPS Next 3Y64.08%
EPS Next 5Y32.83%
Revenue Next Year7.65%
Revenue Next 2Y9.24%
Revenue Next 3Y8.48%
Revenue Next 5Y6.24%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CRI. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 10.74, the valuation of CRI can be described as reasonable.
CRI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CRI is cheaper than 78.57% of the companies in the same industry.
CRI is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.91, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.74 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRI is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as CRI.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.29 | ||
| EV/EBITDA | 9.95 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRI's earnings are expected to grow with 64.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y88.98%
EPS Next 3Y64.08%
5. Dividend
5.1 Amount
CRI has a Yearly Dividend Yield of 1.06%.
Compared to an average industry Dividend Yield of 3.87, CRI's dividend is way lower than its industry peers. On top of this 85.71% of the companies listed in the same industry pay a better dividend than CRI!
With a Dividend Yield of 1.06, CRI pays less dividend than the S&P500 average, which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.06% |
5.2 History
The dividend of CRI decreases each year by -5.16%.
Dividend Growth(5Y)-5.16%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y88.98%
EPS Next 3Y64.08%
EPA:CRI (3/28/2025, 12:40:41 PM)
11.7
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners10.24%
Inst Owner ChangeN/A
Ins Owners64.27%
Ins Owner ChangeN/A
Market Cap290.86M
Analysts76
Price Target14.24 (21.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.06% |
Yearly Dividend0.36
Dividend Growth(5Y)-5.16%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.55%
PT rev (3m)5.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-8.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.74 | ||
| P/S | 0.43 | ||
| P/FCF | 37.29 | ||
| P/OCF | 13.28 | ||
| P/B | 1 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.95 |
EPS(TTM)-0.21
EYN/A
EPS(NY)1.09
Fwd EY9.31%
FCF(TTM)0.31
FCFY2.68%
OCF(TTM)0.88
OCFY7.53%
SpS27.14
BVpS11.75
TBVpS-0.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.55% | ||
| ROE | -1.81% | ||
| ROCE | 4.94% | ||
| ROIC | 3.61% | ||
| ROICexc | 4.35% | ||
| ROICexgc | 9.61% | ||
| OM | 4.76% | ||
| PM (TTM) | N/A | ||
| GM | 26.99% | ||
| FCFM | 1.16% |
ROA(3y)1.98%
ROA(5y)2.57%
ROE(3y)6.62%
ROE(5y)8.73%
ROIC(3y)4.83%
ROIC(5y)5.7%
ROICexc(3y)6.41%
ROICexc(5y)7.76%
ROICexgc(3y)14.55%
ROICexgc(5y)16.89%
ROCE(3y)6.63%
ROCE(5y)7.87%
ROICexcg growth 3Y-36.63%
ROICexcg growth 5Y-17.87%
ROICexc growth 3Y-33.41%
ROICexc growth 5Y-18.68%
OM growth 3Y-18.6%
OM growth 5Y-11.57%
PM growth 3Y-64.16%
PM growth 5Y-45.18%
GM growth 3Y-0.45%
GM growth 5Y-0.47%
F-Score5
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 50.42 | ||
| Debt/EBITDA | 5.39 | ||
| Cap/Depr | 55.95% | ||
| Cap/Sales | 2.09% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 38.22% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 0.83 | ||
| Altman-Z | 1.46 |
F-Score5
WACC6.79%
ROIC/WACC0.53
Cap/Depr(3y)52.41%
Cap/Depr(5y)65.81%
Cap/Sales(3y)2.06%
Cap/Sales(5y)2.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-137.41%
EPS 3Y-67.43%
EPS 5Y-44.13%
EPS Q2Q%-254.53%
EPS Next Y44.78%
EPS Next 2Y88.98%
EPS Next 3Y64.08%
EPS Next 5Y32.83%
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y-7.38%
Revenue growth 5Y2.64%
Sales Q2Q%8.62%
Revenue Next Year7.65%
Revenue Next 2Y9.24%
Revenue Next 3Y8.48%
Revenue Next 5Y6.24%
EBIT growth 1Y-6.41%
EBIT growth 3Y-24.61%
EBIT growth 5Y-9.23%
EBIT Next Year169.06%
EBIT Next 3Y57.99%
EBIT Next 5YN/A
FCF growth 1Y262.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y204.17%
OCF growth 3YN/A
OCF growth 5YN/A